White Collar Law360

 | June 16, 2016

 | Melissa Tearney, Emily Hodge and Sara Frank

Melissa Tearney, Emily Hodge and Sara Frank on the FDA Expanded Access Program

White Collar Law360

 | June 16, 2016

 | Melissa Tearney, Emily Hodge and Sara Frank

View “Expanded Access-A Regulatory Balancing Act For Drug Cost."

Melissa Tearney, Emily Hodge and Sara Frank wrote “Expanded Access-A Regulatory Balancing Act For Drug Cost,” in White Collar Law360, where they discuss how the FDA provides regulations, oversight and guidance to companies over experimental drugs. However, many of the toughest questions are left for manufacturers to resolve on their own as they assess how to grant patients access to an experimental drug in a safe, fair and ethical manner outside the context of a clinical trial.

 

Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client.  Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.

AcceptDecline